Nonocarriers to help prevent kindney rejection after transplant

 

Congratulations to ToleRaM Nanotech, LLC  for winning a National TechConnect Innovation Award, which is meant to recognize innovative technology that has the potential to make a difference in a special sector, such as medicine. Only 15% of submitted entries receive the prestigious award.

ToleRaM Nanotech is a start-up company that grew out of a collaboration among MUSC Health transplant surgeon Satish Nadig, M.D., Ph.D,  biomedical engineer and nanotechnologist Ann-Marie Broome, Ph.D., MBA, and immunologist Carl Atkinson, Ph.D.

ToleRaM Nanotech, LLC was developed to use novel graft targeting nanoparticles to attenuate both acute and chronic rejection after transplant. Learn more by reading Progressnotes article Special Delivery.